Terminated NA INTERVENTIONAL 2-arm NCT02360046

The Influence of Different Hydrocortisone Replacement Doses on the Partitioning and Flexibility of Ectopic Lipids in Patients With Corticotropic Hypopituitarism (Hydrocort)

The Influence of Different Hydrocortisone Replacement Doses on the Partitioning and Flexibility of Ectopic Lipids (Intrahepatocellular IHCL and Intramyocellular IMCL) in Patients With Corticotropic Hypopituitarism, a Randomised Placebo-controlled Double-blind Trial

Sponsor: Insel Gruppe AG, University Hospital Bern

Conditions Fatty Acids, Nonesterified Hydrocortisone Hypopituitarism Insulin Sensitivity Lipids

Interventions Hydrocortisone Placebo

Updated 9 times since 2017 Last updated: Oct 8, 2018 Started: Jan 31, 2015 Primary completion: Dec 31, 2016 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Insel Gruppe AG, University Hospital Bern

See all terminations from Insel Gruppe AG, University Hospital Bern

This NA trial investigates Fatty Acids, Nonesterified and Hydrocortisone and is currently terminated or withdrawn. Insel Gruppe AG, University Hospital Bern leads this study, which shows 9 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Terminated NA
Sep 2024 — Sep 2025 [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jul 2023 — Jul 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2023 [monthly]

Terminated NA

▶ Show 4 earlier versions

Nov 2018 — Jan 2021 [monthly]

Terminated NA

Status: Unknown Status → Terminated
Jun 2018 — Nov 2018 [monthly]

Unknown Status NA
Sep 2017 — Jun 2018 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2017 — Sep 2017 [monthly]

Recruiting NA

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Insel Gruppe AG, University Hospital Bern

Data source: Insel Gruppe AG, University Hospital Bern

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bern, Switzerland